Status:
COMPLETED
Study of the Spread of COVID-19 in Saint Petersburg, Russia
Lead Sponsor:
European University at St. Petersburg
Conditions:
COVID19
Eligibility:
All Genders
18+ years
Brief Summary
Seroprevalence study of COVID-19 in Saint Petersburg, Russia is a regional longitudinal cohort study aiming to evaluate the spread dynamics of the COVID-19 disease in the population of Saint Petersbur...
Detailed Description
At least 1 000 individuals, 18 years old and older, are randomly sampled using random digit dialing from the population of Saint Petersburg, Russia. Random sampling is performed by a survey company on...
Eligibility Criteria
Inclusion
- Individuals sampled from the population of Saint Petersburg, Russia using random digit dialling.
- Subjects aged 18 and older of both genders.
- Asymptomatic at the time of blood draw.
- Written informed consent for a blood draw, SARS-COV-2 antibody test, and data collection.
Exclusion
- Presence of fever or cough or respiratory distress at the time of blood test not attributable to other known chronic disease.
- Age under 18.
- Any health condition that may be a contraindication towards blood sampling in out-patient clinic.
- Residence in Kolpinskiy, Kurortniy, Krasnoselsky, Kronshtadtskiy, Petrodvorcoviy, Pushkinskiy districts of St. Petersburg.
Key Trial Info
Start Date :
May 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
1038 Patients enrolled
Trial Details
Trial ID
NCT04406038
Start Date
May 27 2020
End Date
November 1 2023
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic "Scandinavia"
Saint Petersburg, Russia, 196084